Rossella Galli (R Galli)

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 4

Top Topics

Cancer Stem Cells

Extracellular Matrix

Top Venues

Journal of personalized medicine

Cancer research

AJNR. American journal of neuroradiology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Pieri, Alberto Luigi Gallotti, Denise Drago, Manuela Cominelli, Ilaria Pagano, Valentina Conti, Silvia Valtorta, Angela Coliva, Sara Lago, Daniela Michelatti, Luca Massimino, Federica Ungaro, Laura Perani, Antonello Enrico Spinelli, Antonella Castellano, Andrea Falini, Alessio Zippo, Pietro Luigi Poliani, Rosa Maria Moresco, Annapaola Andolfo, Rossella Galli
Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma. Cancer research (2022)
Eliana Ruggiero, Erica Carnevale, Aaron Prodeus, Zulma Irene Magnani, Barbara Camisa, Ivan Merelli, Claudia Politano, Lorena Stasi, Alessia Potenza, Beatrice Claudia Cianciotti, Francesco Manfredi, Mattia Di Bono, Luca Vago, Michela Tassara, Sara Mastaglio, Maurilio Ponzoni, Francesca Sanvito, Dai Liu, Ishina Balwani, Rossella Galli, Marco Genua, Renato Ostuni, Matteo Doglio, Daniel O'Connell, Ivy Dutta, Stephanie Ann Yazinski, Mark McKee, Mohamed Simo Arredouani, Birgit Schultes, Fabio Ciceri, Chiara Bonini
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function. Science translational medicine 14 (631) (2022)
Sara Tomei, Andrea Volontè, Shilpa Ravindran, Stefania Mazzoleni, Ena Wang, Rossella Galli, Cristina Maccalli
MicroRNA Expression Profile Distinguishes Glioblastoma Stem Cells from Differentiated Tumor Cells. Journal of personalized medicine 11 (4) (2021)
Letterio Salvatore Politi, Gianluca Brugnara, Antonella Castellano, M Cadioli, Luisa Altabella, Marco Peviani, Stefania Mazzoleni, Andrea Falini, Rossella Galli
T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas. AJNR. American journal of neuroradiology 37 (6) (2016)